Status:
COMPLETED
Cytogenetic Study of Ocular Melanoma
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Choroidal Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for ge...
Detailed Description
The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic studies of choroidal melanoma to improve the screening of biopsy samples of choroidal melanoma through cytogeneti...
Eligibility Criteria
Inclusion
- Patient with diagnosis of ocular melanoma
- Patient with local treatment plan for ocular melanoma- plaque brachytherapy or enucleation
- Patient 18 years of age or older
- Archival enucleation specimens with diagnosis of ocular melanoma
Exclusion
- Patient who refuses local melanoma treatment
- Patient who refuses to participate in this study
Key Trial Info
Start Date :
January 8 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 23 2020
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT00344799
Start Date
January 8 2005
End Date
October 23 2020
Last Update
March 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jules Stein Eye Institute
Los Angeles, California, United States, 90095